Ayala Pharmaceuticals Inc (ADXS)

[mpreorder]

Meis - I was in DNDN years before approval and if I remember correctly it was nearly full value well before approval. There was a pop upon approval that pulled back pretty quickly. My point is that approval isn't necessary for most of the value to be realized. I'm looking forward to the discussions at the time as to how to deal with the impending FDA announcement. Personally I might protect my downside with some put options. (Something I should have done last year....)